Inactive primary care patients Not Applicable
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 45-74 years registered at one of the six general practices within the South West London cluster of primary care trusts (PCTs) where the research is being undertaken 2. Able to walk outside the home and with no contraindications to increasing their moderate intensity physical activity levels
Exclusion criteria
Exclusion criteria: 1. Those reporting achieving the Chief Medical Officers' guidelines of at least 150 minutes of at least moderate intensity physical activity weekly. We anticipate that there will be a few participants who will be found on subsequent baseline accelerometer assessment to be above this level of physical activity (our previous pilot work suggests this number will be small as most people tend to overestimate their physical activity levels). They will not be excluded from the study, as this is a pragmatic trial and if this intervention were to be rolled out, exclusion would be on the basis of the screening question alone. 2. Liiving in a residential or nursing home 3. Housebound 4. Three or more falls in previous year or one or more fall in previous year requiring medical attention 5. Terminal illness 6. Dementia or significant cognitive impairment (unable to follow simple instructions) 7. Registered blind 8. New onset chest pain 9. Myocardial infarction 10. Coronary artery bypass graft or angioplasty within the last 3 months 11. Medical or psychiatric condition which the general practitioner (GP) considers excludes the patient (e.g. acute systemic illness such as pneumonia, acute rheumatoid arthritis, unstable or acute heart failure, significant neurological disease or impairment, unable to move about independently, psychotic illness) 12. Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in average daily step-count, assessed objectively by accelerometry (Actigraph GT3X+ Manufacturing Technology Inc, Fl USA), measured over 7 days, between baseline and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Change in time spent in: 1.1. At least moderate intensity physical activity and 1.2. Sedentary physical activity, measured over 7 days by accelerometry, between baseline and 12 months 2. Change in average daily step-count, time spent in at least moderate physical activity and time spent sedentary, assessed objectively by accelerometry measured over 7 days, between baseline and 3 months 3. Cost-effectiveness, incremental cost of the intervention to the NHS and incremental cost per change in step-count and per quality-adjusted life year 4. Acceptability of the interventions (qualitative interviews and focus groups) 5. Change in self-reported physical activity from the questionnaire [General Practice Physical Activity Questionnaire (GPPAQ), International Physical Activity Questionnaire (IPAQ)] 6. Change in other patient reported outcomes from the questionnaire (exercise self-efficacy, anxiety, depression, perceived health status including mood and pain (EuroQol 5D [EQ-5D]) 7. Change in anthropometric measurements (weight, body mass index, waist circumference, body fat, bio-impedence (Tanita scales) 8. Adverse outcomes (data on falls, injuries, major cardiovascular disease events and deaths will be collected as part of safety monitoring for the trial, through participant and nurse reporting, questionnaires at 3 and 12 months and primary care records 9. Health service use - number of and diagnoses for all primary care consultations during the 12 months of the trial, as well as any out of hours, A&E or in-patient attendances related to falls, injuries, fractures etc from computerised primary care records at the end of the study given participants consent 10. There will be a range of outcomes from qualitative interviews and focus groups for both participants and practice nurses involved in impleme | — |
Countries
United Kingdom